Status:
COMPLETED
Internet-based Emotional Awareness and Expression Therapy for Somatic Symptom Disorder - A Randomized Controlled Trial
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Stockholm University
Wayne State University
Conditions:
Somatic Symptom Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main purpose of this study is to conduct a Randomised Controlled Trial (RCT) where we evaluate an internet administrated version of Emotional Awareness and Expression Therapy (I-EAET) in the treat...
Detailed Description
Research background Somatic Symptom Disorder (SSD; DSM-5) is one of the most prevalent disorders encountered in primary care settings (1). Typically in SSD, distressing somatic complaints are accompan...
Eligibility Criteria
Inclusion
- Age over 18 years
- A total score ≥5 on the PHQ-15
- A diagnosis of SSD according to the DSM-5, i.e ≥1 of the 3 of: disproportionate thoughts about the somatic symptom, persistently high level of anxiety, or excessive time and energy devoted in regard to symptoms or health concerns
- Symptom duration ≥6 months
- Written statement from a medical professional that states that a medical evaluation has been conducted.
Exclusion
- Alcohol or substance addiction
- A diagnosis of a psychological condition that might require other treatment (e.g., psychosis, suicidality, etc)
- Other severe medical condition
- Ongoing psychological intervention or psychotherapy that target somatic symptoms
- Ongoing medical treatment that may interfere with the psychological treatment.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2022
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04751825
Start Date
February 1 2021
End Date
April 15 2022
Last Update
June 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institute
Stockholm, Sweden, 17177